---
title: "Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial"
date: "2025-09-10T04:00:00.000Z"
publishedDate: "10 septembre 2025"
summary: "Conditions : Advanced Hepatocellular Carcinoma; Stage III Hepatocellular Carcinoma AJCC v8; Stage IV Hepatocellular Carcinoma AJCC v8 Interventions : Biological: Atezolizumab; Biological: Bevacizumab; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Questionnaire Administration; Biological: Tremelimumab; Biological: Durvalumab; Biological: Nivolumab; Drug: Ipilimumab; Radiation: Stereotactic Body Radiation Therapy; Procedure: Positron Emission Tomography Sponsors : NRG Oncology Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07166406?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-10-testing-immunotherapy-with-or-without-stereotactic-body-radiation-therapy-in-patients-with-advanced-liver-cancer-helio-rt-trial"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Advanced Hepatocellular Carcinoma; Stage III Hepatocellular Carcinoma AJCC v8; Stage IV Hepatocellular Carcinoma AJCC v8 Interventions : Biological: Atezolizumab; Biological: Bevacizumab; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Questionnaire Administration; Biological: Tremelimumab; Biological: Durvalumab; Biological: Nivolumab; Drug: Ipilimumab; Radiation: Stereotactic Body Radiation Therapy; Procedure: Positron Emission Tomography Sponsors : NRG Oncology Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07166406?term=interventional+radiology&aggFilters=status%3A
